legal · go-v.org

Legal · US

225,069 document(s) from the ingested source(s); showing 100.

page 35 of 2251 · 225,069 documents · previous next

Acrylic and modified acrylic plastics, semirigid and rigid.

CFR · 2024-01-01 · US · Title 21

Semirigid and rigid acrylic and modified acrylic plastics may be safely used as articles intended for use in contact with food, in accordance with the following prescribed conditions. The acrylic and modified acrylic polymers or plastics described in this section also may be safely used as components of articles intended for use in contact with food. (a) The optional substances that may be used in the formulation of the semirigid and rigid acrylic and modified acrylic plastics, or in the formulation of acrylic and modified acrylic components of articles, include substances generally recognized as safe in food, substances used in accordance with a prior sanction or approval, substances permitted for use in such plastics by regulations in parts 170 through 189 of this chapter, and substances identified in this paragraph. At least 50 weight-percent of the polymer content of the acrylic and modified acrylic materials used as finished articles or as components of articles shall consist of polymer units derived from one or more of the acrylic or methacrylic monomers listed in paragraph (a)(1) of this section. (1) Homopolymers and copolymers of the following monomers: (2) Copolymers produced by copolymerizing one or more of the monomers listed in paragraph (a)(1) of this section with one or more of the following monomers: (3) Polymers identified in paragraphs (a)(1) and (2) of this section containing no more than 5 weight-percent of total polymer units derived by copolymerization wi

official document · source cfr-2024

Acrylonitrile copolymers and resins.

CFR · 2024-01-01 · US · Title 21

(a) Acrylonitrile copolymers and resins listed in this section, containing less than 30 percent acrylonitrile and complying with the requirements of paragraph (b) of this section, may be safely used as follows: (1) (ii) Acrylonitrile/butadiene copolymers—no restrictions. (iii) Acrylonitrile/butadiene copolymer blended with vinyl chloride-vinyl acetate (optional at level up to 5 percent by weight of the vinyl chloride resin) resin—for use only in contact with oleomargarine. (iv) Acrylonitrile/styrene copolymer—no restrictions. (2) (ii) Polyvinyl chloride resin blended with either acrylonitrile/butadiene copolymer or acrylonitrile/butadiene styrene copolymer mixed with neoprene, for use as components of conveyor belts to be used with fresh fruits, vegetables, and fish. (iii) Acrylonitrile/butadiene/styrene copolymer—no restrictions. (iv) Acrylonitrile/styrene copolymer—no restrictions. (3) (ii) Acrylonitrile/styrene resin—no restrictions. (iii) Acrylonitrile/butadiene copolymer blended with polyvinyl chloride resin—for use only as extruded pipe. (b) Limitations for acrylonitrile monomer extraction for finished food-contact articles, determined by using the method of analysis titled “Gas-Solid Chromatographic Procedure for Determining Acrylonitrile Monomer in Acrylonitrile-Containing Polymers and Food-Simulating Solvents,” which is incorporated by reference. Copies are available from the Center for Food Safety and Applied Nutrition (HFS- (1) In the case of single-use articles ha

official document · source cfr-2024

Acrylonitrile copolymers.

CFR · 2024-01-01 · US · Title 21

Acrylonitrile copolymers may be safely used on an interim basis as articles or components of articles intended for use in contact with food, in accordance with the following prescribed conditions: (a) Limitations for acrylonitrile monomer extraction for finished food-contact articles, determined by a method of analysis titled “Gas-Solid Chromatographic Procedure for Determining Acrylonitrile Monomer in Acrylonitrile-Containing Polymers and Food Simulating Solvents,” which is incorporated by reference. Copies are available from the Center for Food Safety and Applied Nutrition (HFS-200), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: (1) In the case of single-use articles having a volume to surface ratio of 10 milliliters or more per square inch of food contact surface—0.003 milligram/square inch when extracted to equilibrium at 120 °F with food-simulating solvents appropriate to the intended conditions of use. (2) In the case of single-use articles having a volume to surface ratio of less than 10 milliliters per square inch of food contact surface—0.3 part per million calculated on the basis of the volume of the container when extracted to equilibrium at 120 °F with food-simulating solvents appropriate to the intended conditions of use. (3) In the case of repeated-use articles—

official document · source cfr-2024

Acrylonitrile.

CFR · 2024-01-01 · US · Title 29

(a) (2) This section does not apply to exposures which result solely from the processing, use, and handling of the following materials: (i) ABS resins, SAN resins, nitrile barrier resins, solid nitrile elastomers, and acrylic and modacrylic fibers, when these listed materials are in the form of finished polymers, and products fabricated from such finished polymers; (ii) Materials made from and/or containing AN for which objective data is reasonably relied upon to demonstrate that the material is not capable of releasing AN in airborne concentrations in excess of 1 ppm as an eight (8)-hour time-weighted average, under the expected conditions of processing, use, and handling which will cause the greatest possible release; and (iii) Solid materials made from and/or containing AN which will not be heated above 170 °F during handling, use, or processing. (3) An employer relying upon exemption under paragraph (a)(2)(ii) shall maintain records of the objective data supporting that exemption, and of the basis of the employer's reliance on the data, as provided in paragraph (q) of this section. (b) (c) (ii) (2) (d) [Reserved] (e) (ii) For the purposes of this section, employee exposure is that exposure which would occur if the employee were not using a respirator. (2) (3) (ii) If the monitoring required by this section reveals employee exposure to be at or above the action level but at or below the permissible exposure limits, the employer must repeat such monitoring for each such emp

official document · source cfr-2024

Acrylonitrile.

CFR · 2024-01-01 · US · Title 29

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Acrylonitrile.

CFR · 2024-01-01 · US · Title 29

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Acrylonitrile/butadiene/styrene/methyl methacrylate copolymer.

CFR · 2024-01-01 · US · Title 21

Acrylonitrile/butadiene/styrene/methyl methacrylate copolymer identified in this section may be safely used as an article or component of articles intended for use with food identified in table 1 of § 176.170(c) of this chapter as Type I, II, III, IVA, IVB, V, VIB, (except bottles intended to hold carbonated beverages), VIIA, VIIB, VIII and IX, under conditions of use C, D, E, F, and G described in table 2 of § 176.170(c) of this chapter with a high temperature limitation of 190 °F. (a) (b) (c) (2) Residual acrylonitrile monomer content of the finished copolymer articles is not more than 11 parts per million as determined by a gas chromatographic method titled “Determination of Residual Acrylonitrile and Styrene Monomers-Gas Chromatographic Internal Standard Method,” which is incorporated by reference. Copies are available from the Center for Food Safety and Applied Nutrition (HFS-200), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: (d) (2) The finished food-contact article shall yield not more than 0.0025 milligram per square inch of acrylonitrile monomer when exposed to distilled water, 3 percent acetic acid and (e) Acrylonitrile copolymers identified in this section shall comply with the provisions of § 180.22 of this chapter. (f) Acrylonitrile copolymers identified in this

official document · source cfr-2024

Acrylonitrile/butadiene/sty­rene co-polymer.

CFR · 2024-01-01 · US · Title 21

Acrylonitrile/butadiene/styrene copolymer identified in this section may be safely used as an article or component of articles intended for use with all foods, except those containing alcohol, under conditions of use E, F, and G described in table 2 of § 176.170(c) of this chapter. (a) (1) Eighty-four to eighty-nine parts by weight of a matrix polymer containing 73 to 78 parts by weight of acrylonitrile and 22 to 27 parts by weight of styrene; and (2) Eleven to sixteen parts by weight of a grafted rubber consisting of (i) 8 to 13 parts of butadiene/styrene elastomer containing 72 to 77 parts by weight of butadiene and 23 to 28 parts by weight of styrene and (ii) 3 to 8 parts by weight of a graft polymer having the same composition range as the matrix polymer. (b) (c) (2) Residual acrylonitrile monomer content of the finished copolymer articles is not more than 11 parts per million as determined by a gas chromatographic method titled “Determination of Residual Acrylonitrile and Styrene Monomers-Gas Chromatographic Internal Standard Method,” which is incorporated by reference. Copies are available from the Center for Food Safety and Applied Nutrition (HFS-200), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: (d) (2) The finished food-contact article shall yield not more than 0.00

official document · source cfr-2024

Acrylonitrile/styrene copoly-mer modified with butadiene/styrene elastomer.

CFR · 2024-01-01 · US · Title 21

Acrylonitrile/styrene copolymer modified with butadiene/styrene elastomer identified in this section may be safely used as a component of bottles intended for use with foods identified in table I of § 176.170(c) of this chapter as Type VI-B under conditions for use E, F, or G described in table 2 of § 176.170(c) of this chapter. (a) (1) 82-88 parts by weight of a matrix copolymer produced by polymerization of 77-82 parts by weight of acrylonitrile and 18-23 parts of styrene; and (2) 12-18 parts by weight of a grafted rubber consisting of (i) 8-12 parts of butadiene/styrene elastomer containing 77-82 parts by weight of butadiene and 18-23 parts by weight of styrene and (ii) 4-6 parts by weight of a graft copolymer consisting of 70-77 parts by weight of acrylonitrile and 23-30 parts by weight of styrene. (b) (c) (2) Intrinsic viscosity of the matrix copolymer in butyrolactone is not less than 0.5 deciliter/gram at 35 °C, as determined by the method titled “Molecular Weight of Matrix Copolymer by Solution Viscosity,” which is incorporated by reference. Copies are available from the Center for Food Safety and Applied Nutrition (HFS-200), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: (3) Residual acrylonitrile monomer content of the modified copolymer articles is not more than 11

official document · source cfr-2024

Acrylonitrile/styrene copoly-mer.

CFR · 2024-01-01 · US · Title 21

Acrylonitrile/styrene copolymers identified in this section may be safely used as a component of packaging materials subject to the provisions of this section. (a) (b) (2) The optional adjuvants for the acrylonitrile/styrene copolymer identified in paragraphs (c)(1) and (3) of this section are as follows: (c) (d) (e) Acrylonitrile copolymer identified in this section may be used to fabricate beverage containers only if they comply with the specifications of item 3 in paragraph (c) of this section.

official document · source cfr-2024

Acrylosilane resins.

CFR · 2024-01-01 · US · Title 40

(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)

official document · source cfr-2024

Acryloxy alkanoic alkane derivative with mixed metal oxides (generic).

CFR · 2024-01-01 · US · Title 40

(a) (2) The significant new uses are: (i) (ii) (b) (1) (2) (3)

official document · source cfr-2024

Act (52 U.S.C. 30101(19)).

CFR · 2024-01-01 · US · Title 11

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act (The Act).

CFR · 2024-01-01 · US · Title 25

(a)

official document · source cfr-2024

Act and scope.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act ineffective as to other withdrawals.

CFR · 2024-01-01 · US · Title 43

(a) The Act in section 2(c) provides as follows: (b) If the power site lands are also affected by any other type of withdrawal which prevents mining location in whole or in part, the provisions of the Act apply only to the extent that the lands are otherwise open to location.

official document · source cfr-2024

Act of 1878.

CFR · 2024-01-01 · US · Title 43

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act of 1898 (Alaska).

CFR · 2024-01-01 · US · Title 43

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act of 1947.

CFR · 2024-01-01 · US · Title 43

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act of April 30, 1912.

CFR · 2024-01-01 · US · Title 43

(a) Under the provisions of the Act of April 30, 1912 (37 Stat. 106; 43 U.S.C. 334), a further extension of time may be granted for submitting final proof, not exceeding 3 years, where it is shown that, because of some unavoidable delay in the construction of irrigation works intended to convey water to the land embraced in his entry, the claimant is, without fault on his part, unable to make proof of the reclamation and cultivation of said lands within the time limited therefor, but such further extension cannot be granted for a period of more than 3 years nor affect contests initiated for a valid existing reason. (b) An entryman who has complied with the law as to annual expenditures and proof thereof and who desires to make application for extension of time under the provisions of the Act of March 28, 1908, should file with the authorizing officer a statement setting forth fully the facts, showing how and why he has been prevented from making final proof of reclamation and cultivation within the regular period. This statement must be corroborated by two witnesses who have personal knowledge of the facts.

official document · source cfr-2024

Act of February 25, 1925.

CFR · 2024-01-01 · US · Title 43

Applications for further extension of time under the Act of April 30, 1912, and February 25, 1925 (43 Stat. 982; 43 U.S.C. 336), may be made in the same manner, and the same procedure will be followed with respect to such applications as under the Act of March 28, 1908, and the Act of March 4, 1915 (38 Stat. 1161; 43 U.S.C. 335), as amended.

official document · source cfr-2024

Act of March 28, 1908.

CFR · 2024-01-01 · US · Title 43

Under the provisions of the Act of March 28, 1908 (35 Stat. 52; 43 U.S.C. 333), the period of 4 years may be extended, in the discretion of the authorized officer, for an additional period not exceeding 3 years, if, by reason of some unavoidable delay in the construction of the irrigating works intended to convey water to the land, the entryman is unable to make proof of reclamation and cultivation required within the 4 years. This does not mean that the period within which proof may be made will be extended as a matter of course for 3 years. Applications for extension under said act will not be granted unless it be clearly shown that the failure to reclaim and cultivate the land within the regular period of 4 years was due to no fault on the part of the entryman but to some unavoidable delay in the construction of the irrigation works for which he was not responsible and could not have readily foreseen (37 L.D. 332). It must also appear that he has complied with the law as to annual expenditures and proof thereof.

official document · source cfr-2024

Act of international terrorism.

CFR · 2024-01-01 · US · Title 31

The term

official document · source cfr-2024

Act of the Government of Iran.

CFR · 2024-01-01 · US · Title 31

For purposes of § 535.216, an act of the Government of Iran, includes any acts ordered, authorized, allowed, approved, or ratified by the Government of Iran, its agencies, instrumentalities or controlled entities.

official document · source cfr-2024

Act purposes.

CFR · 2024-01-01 · US · Title 7

(a) Borrowers are encouraged to submit requests for accommodation of the Government's lien on the borrower's system in order to facilitate obtaining financing from private lenders for purposes provided in the RE Act. (b) The Administrator will consider requests for the subordination of the Government's lien on after-acquired property which will enable borrowers to obtain financing from private lenders for purposes provided in the Act: Provided, however, that property integral to the operation of projects financed with loans made or guaranteed by RUS shall be financed with funds obtained through lien accommodations instead of lien subordinations, unless the Administrator determines that it is in the Government's interest to do otherwise.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The term

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

“Act” means the Commodity Promotion, Research, and Information Act of 1996, (7 U.S.C. 7411-7425), and any amendments to that Act.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The term

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The term

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 7

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 15

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 22

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 29

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 34

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Act.

CFR · 2024-01-01 · US · Title 34

The publisher provides no abstract for this document; none is invented here.

official document · source cfr-2024

Acting as indenture trustee and creditor.

CFR · 2024-01-01 · US · Title 12

With respect to a debt securities issuance, a national bank may act both as indenture trustee and as creditor until 90 days after default, if the bank maintains adequate controls to manage the potential conflicts of interest.

official document · source cfr-2024

Acting as primary provider.

CFR · 2024-01-01 · US · Title 22

(a) When required by § 96.14(a), the agency or person acts as primary provider and adheres to the provisions in § 96.14(b) through (e). When acting as the primary provider, the agency or person develops and implements a service plan for providing all adoption services and provides all such services, either directly or through arrangements with supervised providers, exempted providers, public domestic authorities, competent authorities, Central Authorities, public foreign authorities, or, to the extent permitted by § 96.14(c), other foreign providers (agencies, persons, or other non-governmental entities). (b) The agency or person has an organizational structure, financial and personnel resources, and policies and procedures in place that demonstrate that the agency or person is capable of acting as a primary provider in any intercountry adoption case and, when acting as the primary provider, provides appropriate supervision to supervised providers and verifies the work of other foreign providers in accordance with §§ 96.45 and 96.46.

official document · source cfr-2024

Acting in a representative capacity.

CFR · 2024-01-01 · US · Title 37

When a patent practitioner acting in a representative capacity appears in person or signs a paper in practice before the United States Patent and Trademark Office in a patent case, his or her personal appearance or signature shall constitute a representation to the United States Patent and Trademark Office that under the provisions of this subchapter and the law, he or she is authorized to represent the particular party on whose behalf he or she acts. In filing such a paper, the patent practitioner must set forth his or her registration number, his or her name and signature. Further proof of authority to act in a representative capacity may be required.

official document · source cfr-2024

Acting officials.

CFR · 2024-01-01 · US · Title 10

Except for the Secretary, the responsibilities and authorities conferred in this part may be exercised by persons who have been designated in writing as acting for, or in the temporary capacity of, the following DOE positions: The Local Director of Security; the Manager; the Director, or the General Counsel. The responsibilities and authorities of the Deputy Director for Security, Office of Environment, Health, Safety and Security may be exercised by persons in senior security-related positions within the Office of Environment, Health, Safety and Security who have been designated in writing as acting for, or in the temporary capacity of, the Deputy Director for Security, Office of Environment, Health, Safety and Security, with the approval of the Director, Office of Environment, Health, Safety and Security.

official document · source cfr-2024

Acting on requests.

CFR · 2024-01-01 · US · Title 42

(a) Upon receipt of a request for health hazard evaluation submitted under this part, NIOSH will determine whether or not there is reasonable cause to justify conducting an investigation. (b) If NIOSH determines that an investigation is justified, a NIOSH officer will inspect the place of employment, collect samples where appropriate, and perform tests necessary to the conduct of a health hazard evaluation, including medical examinations of employees. (c) If NIOSH determines that an investigation is not justified, the requester will be notified in writing of the decision.

official document · source cfr-2024

Acting on requests.

CFR · 2024-01-01 · US · Title 42

(a) Upon receipt of a request for a health assessment submitted under this part, ATSDR will determine, in its discretion, whether or not there is a reasonable basis to justify conducting a health assessment. ATSDR will base this determination on, among other factors: (1) Whether individuals have been exposed to a hazardous substance, for which the probable source of such exposure is a release; (2) The location, concentration, and toxicity of the hazardous substances; (3) The potential for further human exposure; (4) The recommendations of other governmental agencies; and (5) The ATSDR resources available and other ATSDR priorities, such as its responsibilities to conduct other health assessments and health effects studies. (b) Where appropriate, ATSDR will request information from other Federal, State, and local governmental agencies, as well as other persons, pertaining to a facility or release which is the subject of a request from the public to ATSDR to conduct a health assessment. (c) The requestor will be notified in writing of ATSDR's determination that either a health assessment will be performed, a health assessment will not be performed, or that further information concerning the facility or release is required before a decision can be made whether a health assessment will be performed. (d) If a health assessment is not initiated in response to a request from the public, ATSDR shall provide a written explanation to the requestor of why a health assessment is not appr

official document · source cfr-2024

Acting under authority of Coast Guard credential or endorsement.

CFR · 2024-01-01 · US · Title 46

(a) A person employed in the service of a vessel is considered to be acting under the authority of a credential or endorsement when the holding of such credential or endorsement is: (1) Required by law or regulation; or (2) Required by an employer as a condition for employment. (b) A person is considered to be acting under the authority of the credential or endorsement while engaged in official matters regarding the credential or endorsement. This includes, but is not limited to, such acts as applying for renewal, taking examinations for raises of grade, requesting duplicate or replacement credentials, or when appearing at a hearing under this part. (c) A person does not cease to act under the authority of a credential or endorsement while on authorized or unauthorized shore leave from the vessel.

official document · source cfr-2024

Acting within scope of authority.

CFR · 2024-01-01 · US · Title 31

An employee shall not engage in any conduct or activity that is in excess of his or her authority or is otherwise contrary to any law, regulation, or Department policy.

official document · source cfr-2024

Actinomycosis and actinobacillosis.

CFR · 2024-01-01 · US · Title 9

(a) The definition of generalization as outlined for tuberculosis in § 311.2(a) shall apply for actinomycosis and actinobacillosis, and carcasses of livestock with generalized lesions of either such disease shall be condemned. (b) Carcasses of livestock in a well-nourished condition showing uncomplicated localized lesions of actinomycosis or actinobacillosis may be passed for human food after the infected organs or other infected parts have been removed and condemned, except as provided in paragraphs (c) and (d) of this section. (c) Heads affected with actinomycosis or actinobacillosis, including the tongue, shall be condemned, except that when the disease of the jaw is slight, strictly localized, and without suppuration, fistulous tracts, or lymph node involvement, the tongue, if free from disease, may be passed, or, when the disease is slight and confined to the lymph nodes, the head including the tongue, may be passed for human food after the affected nodes have been removed and condemned. (d) When the disease is slight and confined to the tongue, with or without involvement of the corresponding lymph nodes, the head may be passed for human food after removal and condemnation of the tongue and corresponding lymph nodes.

official document · source cfr-2024

Action Plan.

CFR · 2024-01-01 · US · Title 24

(a) (b) (c) (2) (d) (1) (2) (3) (4) (5) (6) (i) The efforts, including notification and outreach efforts, to recruit FSS participants from among eligible families; and, (ii) The actions to be taken to assure that both minority and non-minority groups are informed about the FSS (7) (8) (9) (10) (11) (12) (13) (i) Policies related to the modification of goals in the ITSP; (ii) The circumstances in which an extension of the Contract of Participation may be granted; (iii) Policies on the interim disbursement of escrow, including limitations on the use of the funds (if any); (iv) Policies regarding eligible uses of forfeited escrow funds by families in good standing; (v) Policies regarding the re-enrollment of previous FSS participants, including graduates and those who exited the program without graduating; (vi) Policies on requirements for documentation for goal completion; (vii) Policies on documentation of the household's designation of the “head of FSS family;” and (viii) Policies for providing an FSS selection preference for porting families (if the PHA elects to offer such a preference). (e) (f)

official document · source cfr-2024

Action after expungement or reexamination.

CFR · 2024-01-01 · US · Title 37

Upon termination of an expungement or reexamination proceeding, the Office shall issue a notice of termination that memorializes the final disposition of the proceeding as to each of the goods and/or services at issue in the proceeding. Where appropriate, the registration will be cancelled, in whole or in part.

official document · source cfr-2024

Action after final decision.

CFR · 2024-01-01 · US · Title 32

(a) (b) (1) The Executive Director will furnish the Defense Finance and Accounting Service (DFAS) with AFBCMR decisions potentially affecting monetary entitlement or benefits. DFAS will treat such decisions as claims for payment by or on behalf of the applicant. (2) DFAS settles claims on the basis of the corrected military record. Computation of the amount due, if any, is a function of DFAS. Applicants may be required to furnish additional information to DFAS to establish their status as proper parties to the claim and to aid in deciding amounts due. (3) Earnings received from civilian employment during any period for which active duty pay and allowances are payable will be deducted from the settlement. Amounts found due will be offset by the amount of any existing indebtedness to the government in compliance with the Debt Collection Act of 1982 or successor statutes. (c)

official document · source cfr-2024